RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX:ISR - News) a medical isotope company focused on the treatment of prostate cancer and other malignant disease through use of its proprietary radioisotope technology, has scheduled its first quarter fiscal 2008 earnings release for Thursday, November 8, 2007 before the American Stock Exchange opens.
